Infanrix-IPV+Hib

Infanrix-IPV+Hib Indications/Uses

Manufacturer:

GlaxoSmithKline Indonesia
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
Infanrix-IPV+Hib is indicated for active immunization in infants from the age of 2 months against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b.
Infanrix-IPV+Hib is also indicated as a booster dose for children who have previously been immunized with diphtheria, tetanus, pertussis (DTP), polio and Hib antigens.
Infanrix-IPV+Hib does not protect against diseases caused by other types of Haemophilus influenzae nor against meningitis caused by other organisms.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in